Nosocomial infections causedby Pseudomonas aeruginosa in cancer clinics

The purpose of the study was to evaluate the frequency of isolation of multi-resistant Pseudomonas aeruginosa and identify the mechanisms of resistance to carbapenems.Material and methods. We analyzed 866 strains of Pseudomonos aeruginosaisolated from clinical samples from cancer patients in the per...

Full description

Saved in:
Bibliographic Details
Main Authors: N. V. Dmitrieva, M. V. Eidelshtein, V. V. Aginova, I. N. Perukhova, Z. V. Grigorievskaya, N. S. Bagirova, I. V. Tereshchenko, E. V. Kulaga, I. A. Klyuchnikova, E. N. Sokolova, E. A. Shek, E. Yu. Skleenova
Format: Article
Language:Russian
Published: Russian Academy of Sciences, Tomsk National Research Medical Center 2019-04-01
Series:Сибирский онкологический журнал
Subjects:
Online Access:https://www.siboncoj.ru/jour/article/view/1011
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849699954615910400
author N. V. Dmitrieva
M. V. Eidelshtein
V. V. Aginova
I. N. Perukhova
Z. V. Grigorievskaya
N. S. Bagirova
I. V. Tereshchenko
E. V. Kulaga
I. A. Klyuchnikova
E. N. Sokolova
E. A. Shek
E. Yu. Skleenova
author_facet N. V. Dmitrieva
M. V. Eidelshtein
V. V. Aginova
I. N. Perukhova
Z. V. Grigorievskaya
N. S. Bagirova
I. V. Tereshchenko
E. V. Kulaga
I. A. Klyuchnikova
E. N. Sokolova
E. A. Shek
E. Yu. Skleenova
author_sort N. V. Dmitrieva
collection DOAJ
description The purpose of the study was to evaluate the frequency of isolation of multi-resistant Pseudomonas aeruginosa and identify the mechanisms of resistance to carbapenems.Material and methods. We analyzed 866 strains of Pseudomonos aeruginosaisolated from clinical samples from cancer patients in the period 2014–2016. the level of resistance to piperacillin/tazobactam, ceftazidime, cefepime, imipenem, meropenem, ciprofloxacin, amikacin in dynamics was determined. carbapenem-resistant (car-R) strains were examined for the presence of enzymes.Results. Between 2014 and 2016, the number of strains resistant to piperacillin/tazobactam was 20.1–12.9 %, to ceftazidime – 33.0–32.9 %, to cefepime – 25.6–32.9 %, ciprofloxacin – 36.8–43.8 %, amikacin – 23.8–24.9 %. No statistically significant differences were found (p>0.05). However, an increase in the number of car-R strains from 31.7 to 43.8 % was observed (p<0.05). of 7 strains of P. aeruginosainvestigated for the presence of acquired carbapenemases, the production of metal-beta-lactamase of group Vimwas detected in 2 strains, and class acarbapenemases of the gEs-5 group in one strain.Conclusion. P. aeruginosaresistance to all antibiotic groups did not exceed 50 % and remained almost unchanged for 3 years, with the exception of the increase in car-R strains. three out of 7 (42.9 %) carbapenem-resistant strains were genetically stable.
format Article
id doaj-art-0004cc96095c404bbb1e14cd3c846a69
institution DOAJ
issn 1814-4861
2312-3168
language Russian
publishDate 2019-04-01
publisher Russian Academy of Sciences, Tomsk National Research Medical Center
record_format Article
series Сибирский онкологический журнал
spelling doaj-art-0004cc96095c404bbb1e14cd3c846a692025-08-20T03:18:26ZrusRussian Academy of Sciences, Tomsk National Research Medical CenterСибирский онкологический журнал1814-48612312-31682019-04-01182283410.21294/1814-4861-2019-18-2-28-34623Nosocomial infections causedby Pseudomonas aeruginosa in cancer clinicsN. V. Dmitrieva0M. V. Eidelshtein1V. V. Aginova2I. N. Perukhova3Z. V. Grigorievskaya4N. S. Bagirova5I. V. Tereshchenko6E. V. Kulaga7I. A. Klyuchnikova8E. N. Sokolova9E. A. Shek10E. Yu. Skleenova11N.N. Blokhin National Medical Research Center of Oncology.Research Institute of Antimicrobial Chemotherapy, Smolensk State Medical University.N.N. Blokhin National Medical Research Center of Oncology; Medical college №1.N.N. Blokhin National Medical Research Center of Oncology.N.N. Blokhin National Medical Research Center of Oncology.N.N. Blokhin National Medical Research Center of Oncology.N.N. Blokhin National Medical Research Center of Oncology.N.N. Blokhin National Medical Research Center of Oncology.N.N. Blokhin National Medical Research Center of Oncology.N.N. Blokhin National Medical Research Center of Oncology.Research Institute of Antimicrobial Chemotherapy, Smolensk State Medical University.Research Institute of Antimicrobial Chemotherapy, Smolensk State Medical University.The purpose of the study was to evaluate the frequency of isolation of multi-resistant Pseudomonas aeruginosa and identify the mechanisms of resistance to carbapenems.Material and methods. We analyzed 866 strains of Pseudomonos aeruginosaisolated from clinical samples from cancer patients in the period 2014–2016. the level of resistance to piperacillin/tazobactam, ceftazidime, cefepime, imipenem, meropenem, ciprofloxacin, amikacin in dynamics was determined. carbapenem-resistant (car-R) strains were examined for the presence of enzymes.Results. Between 2014 and 2016, the number of strains resistant to piperacillin/tazobactam was 20.1–12.9 %, to ceftazidime – 33.0–32.9 %, to cefepime – 25.6–32.9 %, ciprofloxacin – 36.8–43.8 %, amikacin – 23.8–24.9 %. No statistically significant differences were found (p>0.05). However, an increase in the number of car-R strains from 31.7 to 43.8 % was observed (p<0.05). of 7 strains of P. aeruginosainvestigated for the presence of acquired carbapenemases, the production of metal-beta-lactamase of group Vimwas detected in 2 strains, and class acarbapenemases of the gEs-5 group in one strain.Conclusion. P. aeruginosaresistance to all antibiotic groups did not exceed 50 % and remained almost unchanged for 3 years, with the exception of the increase in car-R strains. three out of 7 (42.9 %) carbapenem-resistant strains were genetically stable.https://www.siboncoj.ru/jour/article/view/1011pseudomonas aeruginosacancer patientscarbapenemase productsvimgesnosocomial infectionsantibacterial drugs
spellingShingle N. V. Dmitrieva
M. V. Eidelshtein
V. V. Aginova
I. N. Perukhova
Z. V. Grigorievskaya
N. S. Bagirova
I. V. Tereshchenko
E. V. Kulaga
I. A. Klyuchnikova
E. N. Sokolova
E. A. Shek
E. Yu. Skleenova
Nosocomial infections causedby Pseudomonas aeruginosa in cancer clinics
Сибирский онкологический журнал
pseudomonas aeruginosa
cancer patients
carbapenemase products
vim
ges
nosocomial infections
antibacterial drugs
title Nosocomial infections causedby Pseudomonas aeruginosa in cancer clinics
title_full Nosocomial infections causedby Pseudomonas aeruginosa in cancer clinics
title_fullStr Nosocomial infections causedby Pseudomonas aeruginosa in cancer clinics
title_full_unstemmed Nosocomial infections causedby Pseudomonas aeruginosa in cancer clinics
title_short Nosocomial infections causedby Pseudomonas aeruginosa in cancer clinics
title_sort nosocomial infections causedby pseudomonas aeruginosa in cancer clinics
topic pseudomonas aeruginosa
cancer patients
carbapenemase products
vim
ges
nosocomial infections
antibacterial drugs
url https://www.siboncoj.ru/jour/article/view/1011
work_keys_str_mv AT nvdmitrieva nosocomialinfectionscausedbypseudomonasaeruginosaincancerclinics
AT mveidelshtein nosocomialinfectionscausedbypseudomonasaeruginosaincancerclinics
AT vvaginova nosocomialinfectionscausedbypseudomonasaeruginosaincancerclinics
AT inperukhova nosocomialinfectionscausedbypseudomonasaeruginosaincancerclinics
AT zvgrigorievskaya nosocomialinfectionscausedbypseudomonasaeruginosaincancerclinics
AT nsbagirova nosocomialinfectionscausedbypseudomonasaeruginosaincancerclinics
AT ivtereshchenko nosocomialinfectionscausedbypseudomonasaeruginosaincancerclinics
AT evkulaga nosocomialinfectionscausedbypseudomonasaeruginosaincancerclinics
AT iaklyuchnikova nosocomialinfectionscausedbypseudomonasaeruginosaincancerclinics
AT ensokolova nosocomialinfectionscausedbypseudomonasaeruginosaincancerclinics
AT eashek nosocomialinfectionscausedbypseudomonasaeruginosaincancerclinics
AT eyuskleenova nosocomialinfectionscausedbypseudomonasaeruginosaincancerclinics